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Background: Osteoporosis (OP) is one of the most serious diseases in the modern world, and OP patients
frequently suffer from fragility fractures in the hip, spine and wrist, resulting in a limited quality of life. Although
bisphosphonates (BPs) are the most effective class of anti-bone-resorptive drugs currently available and the most
commonly prescribed for the clinical treatment of OP, they are known to cause serious side effects such as
bisphosphonate-related osteonecrosis of the jaw. Novel therapeutic materials that can replace the use of BPs have
therefore been developed.
Methods: We commenced an institutional collaborative project in which candidates of herbal extracts were
selected from more than 400 bioactive herbal products for their potential therapeutic effects not only in OP, but
also in oral and skeletal diseases. In the present study, we report on 3 Chinese medical herbal extracts from the
root barks of Melia azedarach, Corydalis turtschaninovii, and Cynanchum atratum.
Results: All of these extracts inhibited osteoclast proliferation and induced apoptosis by up-regulation of caspase
activity and increase of mitochondrial pro-apoptotic proteins expression. Furthermore, the extracts enhanced
differentiation, but did not affect proliferation of both osteoblasts and chondrocytes. The osteo-inducible effect
was also observed in cultured primary bone marrow cells.
Conclusions: Although these extracts have been utilized in traditional Chinese medicine for hundreds of years,
there are no reports to our knowledge, on their therapeutic effects in OP. In this study, we elucidate the potency
of these herbal extracts as novel candidates for OP therapy.
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Osteoporosis (OP) is one of the most serious diseases in
the modern world, and OP patients frequently suffer
from fragility fractures in the hip, spine and wrist, resulting
in a limited quality of life. OP is often observed in elderly
people, particularly postmenopausal women, and is
caused by an imbalance between bone formation and
bone resorption (reviewed in ref. [1-3]). Bisphosphonates
(BPs) are the most effective class of anti-resorptive drugs
currently available and are frequently used in the clinical* Correspondence: mukudai@dent.showa-u.ac.jp
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reproduction in any medium, provided the ortreatment of OP, owing to the great advantages. Despite
showing clinically beneficial effects in the treatment of OP,
serious side effects of BPs have been reported, including
bisphosphonate-related osteonecrosis of the jaw (BRONJ)
[4]. Medical practitioners and basic researchers have
therefore focused on the use of novel therapeutic materials
such as anabolic and hormone-like agents that can replace
and/or reduce the use of BPs.
In recent decades, Chinese medical herbal extracts
have been extensively investigated for their effects on
proliferation and differentiation of osteoclasts (OCs)
and osteoblasts (OBs) in vitro, and/or therapeutic potency
in OP in vivo (e.g., Cistanche salsa [5], Anoectochilus
formosanus [6], Acanthopanax senticosus [7], Herbal Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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identify more candidates of herbal extracts that have
therapeutic effects not only in OP, but are also effective in
the treatment of oral and skeletal diseases, an institutional
collaborative project between Showa University and Tokyo
University of Marine Science and Technology was launched
in 2010 [13]. Within this project, more than 400 bioactive
herbal products were examined. After screening of the
products by an osteoclast-formation-inhibition experiment
utilizing RAW264.7 cells, 3 Chinese medical herbs, the root
barks Melia azedarach (M. azedarach; commonly known
as bead-tree or Cape lilac), Corydalis turtschaninovii
(C. turtschaninovii; crested lark), and Cynanchum atratum
(C. atratum; swallowwort) were chosen for further
investigation. Although water or ethanol extracts of
the roots were reported to contain biologically-active
chemicals [14-19], the main compounds and precise
mechanisms for the pharmacological effects of the extracts
are unknown. In the present study, we reveal that these
herbal extracts not only induce apoptosis of mature OCs,
but also increase differentiation of OBs and chondrocytes
in vitro. These findings suggest the feasibility of the use of
these herbal extracts as novel therapeutics in OP.
Methods
Preparation of the root bark and BP
Approximately 400 kinds of dry herbal roots, including
M. azedarach, C. turtschaninovii and C. atratum, were
imported from China. The plant materials were formally
surveyed and identified by Laboratory of Nutraceuticals
and Functional Foods Science, Graduate School of Marine
Science and Technology. The dry powdered roots (100 g)
were extracted and concentrated to 1 mg/ml under
reduced pressure as described previously [6]. Alendronate
(AD; Wako Pure Chemical Industries, Osaka, Japan) was
used as a BP control, and added at a final concentration of
0.01 to 100 μM into the culture medium.
Cell culture
RAW264.7 cells (mouse monocytes) were cultured and
allowed to differentiate into OCs, as described previously
[20]. MC3T3E1 cells (mouse osteoblastic cells) were
cultured in α-minimum essential medium (MEM)
supplemented with 10% fetal bovine serum (FBS) and
Osteoblast-Inducer Reagent, a cocktail of L-ascorbic
acid, dexamethasone and β-glycerophosphoric acid,
(Takara Bio, Shiga, Japan), and ATDC5 cells (mouse
chondrosarcoma cells) were cultured in Dulbecco’s
modified Eagle’s medium nutrient mixture F-12 Ham
(DMEM/F-12) supplemented with 10% FBS and Insulin-
Transferrin-Sodium selenite Supplement (Roche Diagnostics,
Indianapolis, IN). Normal mouse bone marrow (MBM)
cells from 8- to 9-wk-old female ICR mice were purchased
from Takara Bio, and grown in RPMI 1640 mediumsupplemented with 10% FBS, according to the manufac-
turer’s protocol. All cells were grown at 37°C, 5% CO2 and
100% humidity.
Histochemistry
Cells were seeded at a density of 3 × 103 cells/ well in
48-well cell culture plates and permitted to grow to
maturation for 3 (for RAW264.7 and MBM cells) or
7 days (for MC3T3 and ATDC5 cells) as described above.
Thereafter, the herbal extracts (1, 10 and 100 μg/ml) or
AD were added to the medium (0.5 ml/ well). After 3 days,
the cells were stained for tartrate-resistant acid phosphatase
(TRAP) [20] and alkaline phosphatase (ALPase) activity
[21] and also stained with crystal violet [22], toluidine blue
[22] and alizarine red [23], as described previously, with
slight modification.
Cell viability and apoptosis assays
For 3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium
bromide (MTT) assay, the cells were seeded at a density of
1 × 103 cells/ well in 96-well cell culture plates (100 μl
medium in each well). Once the cells were differentiated,
herbal extracts or BP were added as described above, and
the MTT assay was performed as described previously
[24]. The activities of caspase 3/7, 8 and 9 were mea-
sured by Caspase-Glo (Promega, Madison, WI) and
GloMax-Multi + Detection System (Promega), according to
the manufacturer’s protocol. Genomic DNA fragmentation
was investigated using a commercial kit (Apopladder EX,
Takara), according to the manufacturer’s protocol.
Western blotting analysis
Total cellular protein was prepared as described previously
[25], protein concentration was measured by Quick Start
Bradford Reagent (Bio-rad, Hercules, CA) using bovine
serum albumin as a standard, and aliquots were
stored at -80°C until use. Twenty micrograms of protein
was subjected to sodium dodecyl sulfate polyacrylamide
electrophoresis (SDS-PAGE) in 4- 20% gradient gel
(Bio-Rad), and the blot was transferred onto polyvinyli-
dene difluoride membrane (Life Technologies, Carlsbad,
CA). Blocking, incubation with primary and horseradish
peroxidase-conjugated secondary antibodies and washing
of the blots were carried out as previously described [25].
Subsequently, the signal was visualized using Amersham
ECL Western Blotting Detection Reagents (GE Healthcare
UK Ltd., Buckinghamshire, UK) and ChimiDoc XRS Plus
ImageLab System (Bio-Rad). The primary and secondary
antibodies were purchased from Cell Signaling Technology
(Danvers, MA) and GE Healthcare, respectively.
Biochemical assays
Cells were seeded at a density of 3 × 103 cells/ well in
24-well cell culture plates and cultured as described above in
Table 1 The genes, primer sequence for sense (upper row)
and anti-sense (lower row) strands references and GenBank
accession numbers utilized for real-time PCR are shown
Gene Primer sequence Reference GenBank
accession No
ALPase 5′-TGACCTTCTCTCCTCCATCC-35′ [26] NM_007431
5′-CTTCCTGGGAGTCTCATCCT-3′
Osteocalcin 5′-TGCTTGTGACGAGCTATCAG-3′ [26] NM_007541
5′-GAGGACAGGGAGGATCAAGT-3′
Col II α1 5′-ACTGGTAAGTGGGGCAAGAC-3′ [26] NM_031163
5′-CCACACCAAATTCCTGTTCA-3′
Aggrecan 5′-AGGACCTGGTAGTGCGAGTG-3′ [27] NM_007424
5′-GCGTGTGGCGAAGAA-3′
β-actin 5′-AGATGTGGATCAGCAAGCAG-3′ [26] NM_007393
5′-GCGCAAGTTAGGTTTTGTC-3′
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Thereafter, cells were lysed with 0.3 ml of 0.02% Triton
X-100 (Sigma Aldrich, St. Louis, MO) in physiological
saline, sonicated, and stored at -80°C until use. DNA and
sulfated glycosaminoglycan (GAG) content were measured
as described previously [22], and ALPase activity was assayed
with a commercial kit (pNPP Phospatase Assay Kit, BioAssay
Systems, Hayward, CA). Calcium and PO4 content were also
measured with commercial kits (Calcium C-test and
Phosphor C-test, Wako). Meanwhile, the conditioned
medium (CM) of cultured cells was collected, centrifuged
at 1 × 104 g for 5 min at 4°C, concentrated with Amicon
Ultra-0.5 ml 3 k (Merck Millipore, Billerica, MA), and the
resulting aliquot (25 μl) was subjected to enzyme-linked
immunosorbent assay (ELISA) for mouse osteocalcin using
a commercial kit (Mouse Osteocalcin EIA Kit, Biomedical
Technologies, Stoughton, MA). Osteocalcin content and
activity were normalized to DNA content in the cell layer
lysate.
RNA isolation and real-time PCR analysis
Cells were seeded in a 24 well culture plate, and cultured
as described above (1 ml medium/ well). Total RNA was
purified using a commercial kit (NucleoSpin RNA II,
Macherey-Nagel, Düren, Germany), and single-strand
cDNA was reverse-transcribed from a 100 ng aliquot
of total RNA using a random nonamer and MV Reverse
Transcription XL (Takara Bio) according to the manufac-
turer’s protocol. Real-time PCR was performed with the
SYBR green system (MyiQ2; Bio-Rad). One nanogram of
each cDNA was used as a template, under conditions of 1
nM of each primer pair and 10 μl of the 2× iQ SYBR
Green Supermix (Bio-Rad) in a total volume of 20 μl. The
primer sequences are as shown in Table 1. Statistical
analysis was performed using Bio-Rad iQ5 analysis software.
Gene expression was first normalized to β-actin within each
sample group and the fold change in gene expression was
calculated using the 2−ΔΔCt method.
Statistical analysis
Unless otherwise specified, all experiments were repeated
at least three times, and similar results were obtained
in the repeated experiments. The two-tailed, unpaired
Student’s t-test was used for analysis. Data are ex-
pressed as means ± standard deviation of triplicate data.
A P-value < 0.05 was considered significant.
Results
Assessment of optimal dosage of alendronate used as an
apoptosis-inducible control
Before commencement of the final screening of herbal
extracts, the optimal dosage of AD was examined in the
three cell lines (RAW264.7, MC3T3E1 and ATDC5 cells)
that were subjected to final screening (Figure 1). At lowconcentrations (0.01 to 1 μM), AD had negligible effects
on either cell viability or caspase activities. A dose of
10 μM of AD, however, effectively reduced cell viability
represented by MTT assay, and induced activation of
caspases, indicating that all of the cells underwent
apoptosis. Furthermore, 100 μM of AD decreased not
only cell viability, but also caspase activities. These
results indicated that a concentration greater than
10 μM induces not only apoptosis, but also necrosis
due to cytotoxicity, resulting in relative decrease both
of MTT and of caspase activities. Based on these data, we
chose to use 10 μM of AD as an apoptosis-inducible
control in the following experiments.
In vitro screening of herbal extracts utilizing TRAP
staining in OCs
As described in our recent study [13], more than 400
bioactive herbal extracts were subjected to in vitro
preliminary screening in which differentiated OCs
from RAW264.7 cells were cultured in the presence
of the extracts for 3 days. During this screening pro-
cedure, extracts that demonstrated growth-inhibitory
or apoptosis-inducing effects on OCs, which were induced
from RAW264.7 cells, were selected. These selected
extracts were subjected to secondary screening whereby
differentiated OBs from MC3T3E1 cells and chondrocytes
from ATDC5 cells were cultured in the presence of the
extracts for 3 days. Finally, extracts that did not induce
cell death were selected. As a result, 3 herbal extracts from
the root bark of 1) M. azedarach, 2) C. turtschaninovii
and 3) C. atratum were determined to be adequate
for the present study and were utilized in the following
experiments. Figure 2 shows the effects of these extracts
and AD on RAW264.7 cells by crystal violet and
TRAP staining. In cells treated with the control, TRAP-
positive, multinuclear and giant cells, which reflect a
Figure 1 Optimal dosage of AD used as an apoptosis-inducible positive control. RAW264.7 (closed box), MC3T3E1 (open box) and ATDC5
(shaded box) cells were seeded at a density of 1×104 cells/well in 96-well tissue culture plates, and grown in the absence (Cont) or presence of
0.01 to 100 μM of AD. After 24 h, cells were subjected to MTT (A), and caspase 3/7 (B), 8 (C) and 9 (D) assays. Data are means ± standard deviation of
the values from 3 sets of cultures. *, p < 0.05 vs each control.
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the herbal extracts at a concentration of 1 μg/ml slightly
decreased the number of total and OC-induced cells. This
growth-inhibitory effect was more pronounced in cultures
treated with 10 μg/ml or more of the herbal extracts,
and occurred in a dose-dependent manner. Moreover,
at a concentration of 100 μg/ml, OC-like cells were
barely detectable by TRAP staining, and cell number was
drastically reduced as shown by crystal violet staining.
These results were also observed in cell cultures to which
AD was added.
The herbal extracts induce apoptosis in OCs via activation
of caspases
We investigated the mechanism by which the extracts
decrease cell number of OCs. Results from the MTT assay
(Figure 3A) showed more accurately that all of the
extracts decreased cell viability more than by treatment
with AD. The caspase assays (Figure 3B, C and D) revealed
that this effect on cell viability was dependent on up-
regulation of the activities of caspase 3/7, 8 and 9 in control
and extract-treated cells. The concentration at whichmaximal effects were observed as well as the specific
caspase that demonstrated the greatest up-regulation in
activity, however, differed for each extract. Treatment with
the extracts also resulted in DNA fragmentation (Figure 3E)
suggesting that these herbal extracts can induce not only
growth inhibition, but also apoptosis in induced OCs.
Further investigation into the apoptotic effects of the
extracts was carried out by Western blot analysis for
several apoptosis-related molecules (Figure 4). Treatment
with the herbal extracts resulted in a robust increase in
the mitochondria-related pro-apoptotic proteins Bax,
Bad and Bak, except for Bid, whereas changes in the
pro-survival proteins, Bcl-2 and Bcl-XL were not observed.
In contrast, protein expression of p53 was increased only
by AD. These results suggest that the apoptotic effects of
the herbal extracts might be regulated by up-regulation of
a mitochondria-related apoptotic pathway.
The herbal extracts do not enhance proliferation but
induce differentiation of OBs
Since the herbal extracts caused drastic growth-inhibitory
and apoptosis-inducible effects in induced OCs, we
Figure 2 Inhibition of mutation and induction of cell death in OCs by incubation with herbal extracts. RAW 264.7 cells were seeded and
allowed to differentiate into OCs. The cells were then cultured in the absence (Control) or presence of 10 μM AD, or 1, 10 and 100 μg/ml C.
atratum, M. azedarach and C. turtschaninovii extracts. After 3 days, cells were stained with crystal violet and TRAP and examined with a
microscope at a magnification of 40× and 100×. Bar, 1 mm (40×) and 100 μm (100×).
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Figure 3 Apoptotic effects of the herbal extracts on OCs. RAW264.7 cells were seeded in 96-well cell culture plates and allowed to differentiate
into OCs. Cells were cultured in the absence (Control) or presence of 10 μM AD, or 1, 10 and 100 μg/ml C. atratum (Atratum) M. azedarach (Azedarach)
and C. turtschaninovii (Turtschaninovii) extracts. After 3 days, the cells were subjected to MTT (A), caspase 3/7 (B), 8 (C) and 9 (D) assays. The genomic
DNA fragmentation assay (E) was carried out using a commercial kit, according to the manufacturer’s protocol. In the left adjacent lane, a 100 bp DNA
ladder (Takara) was applied; bold bans indicate 1000 and 500 bp. Data in panel a to d are means ± standard deviations of 3 cultures, and each mean is
valued relatively as “1.” *, p < 0.05 vs control.
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MC3T3E1 cells, an OB cell line (Figures 5 and 6). We did
not observe effects of the extracts on cell proliferation, as
demonstrated by crystal violet staining (Figure 5, CV),
MTTassay (Figure 6A) and DNAmeasurement (Figure 5B).
AD inhibited growth and differentiation of OB. Conversely,
treatment with the extracts resulted in increased ALPase
activity (Figure 5, ALP and Figure 6C) and osteocalcin
secretion (Figure 6D) that are markers of differentiation in
OBs. Furthermore, a concentration of 100 μg/ml of
the extract of C. atratum enhanced calcification of theextra-cellular matrix (ECM), as shown by alizarin red
staining (Figure 5, AR), in addition to Ca and PO4 assays
(Figure 6E and F). Real-time RT-PCR (Figure 6G and H)
revealed that addition of the extracts increased mRNA of
osteocalcin and ALPase, confirming the results of histo-
chemical and biochemical assays. In particular, mRNA
expression of ALPase was increased in a dose-dependent
manner by treatment with the extracts, whereas that of
osteocalcin did not always do. Thus, these results reveal the
potential ability of the herbal extracts to act as therapeutic
agents in OP.
Figure 4 Modulation of apoptosis-related proteins by stimulation
with herbal extracts. RAW264.7 cells were allowed to differentiate
into OCs. a. The cells were seeded at a density of 1×105 cells /well in
6-well culture plates, and allowed to differentiate into osteoclasts by
the addition of RANKL. Thereafter, the cells were cultured in the
absence (Cont) or presence of 10 μM AD, or 1, 10 and 100 μg/ml
C. atratum (Atratum) M. azedarach (Azedarach) and C. turtschaninovii
(Turtschan) extracts. After 3 days, total cellular protein was collected,
and 20 μg of the aliquot was subjected to Western Blotting analysis for
Bax, Bad, Bak, Bid Bcl-2, Bcl-XL, p53 and GAPDH, sequentially.
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chondrocytes, but do not affect synthesis of
cartilage-specific ECM
Our next step was to determine the biological effects of the
herbal extracts on chondrocytes. ATDC5 cells were
cultured in the presence of the extracts for 1 week,
and then subjected to histochemical staining (Figure 7)
and biochemical assays (Figure 8). We did not observe sig-
nificant effects of the herbal extracts on cell proliferation
as shown by crystal violet staining (Figure 7, CV), MTT
assay (Figure 8A) and DNA measurement (Figure 8B),
although AD was able to decrease cell viability. Similar
to the results observed in MC3T3E1 cells. Although
histochemical staining (Figure 7, ALP) showed little
difference, biochemical measurement (Figure 8C) was
capable of representing the up-regulated ALPase activity
by all of the extracts at a concentration of 1 μg/ml, and
stronger effects were observed with concentrations greater
than 10 μg/ml. Nonetheless, accumulation of sulfated
GAG (Figure 7, TB and Figure 8D) in the cartilage ECM
was similar in the presence or absence of the extracts. For
more detailed assessment of effects on ECM synthesis,
real-time RT-PCR for aggrecan core protein (Figure 8E)
and type II collagen (Figure 8F) was carried out. The
results not only corroborated those from cytochemistryand bioassays, but also clarified the effects of the extracts,
particularly on ALPase activity. Although RT-PCR for type
X collagen was also carried out, the threshold cycle (Ct) in
each condition was more than 45, indicating rare gene
expression (data not shown). Therefore, in agreement with
the results from the bioassay, the herbal extracts showed
little effect (p > 0.05) on gene expression. These data sug-
gest that the herbal extracts may play a role in increasing
direct ossification of cartilage tissue but not maturation.
The herbal extracts induce osteoblastic, but not
osteoclastic differentiation in primary bone marrow cells
In the above experiments, three cell lines were used.
Finally, we investigated whether the effects of the herbal
extracts are observed in a primary mouse bone marrow
(MBM) cells (Figure 9). Seven days after seeding, few
cells (< 50%) survived in all conditions. However, the
live cells differentiated into two populations, one was
ALPase-positive; the other was TRAP-positive. This
observation was more pronounced in the presence of
Osteoblast-Inducer Reagent, particularly in low dosage of
the extracts. The addition of herbal extracts resulted in an
increased number of ALPase-positive cells. In contrast, no
TRAP-positive cells were detected, even in the presence
of Osteoblast-Inducer Reagent. These results indicate
that the extracts induced differentiation of bone marrow
stem cells into OBs, but not OCs, and strongly suggest the
clinical utility of these herbal extracts as a therapeutic
against OP.
Discussion
A number of basic and clinical studies investigating
chemical treatment for OP, including parathyroid hor-
mone (PTH), vitamin D3 and selective estrogen receptor
modulator (SERM), have been reported. Currently, BPs
are widely used as a therapeutic medicine for OP, as well
as bone-metastatic cancers, since they effectively inhibit
bone resorption. Despite great pharmacological and
clinical advantages of BPs, however, serious side effects,
such as renal failure and BRONJ, have also been reported
[4]. This suggests an urgent need for the identification and
development of novel medicines. Botanical therapeutics are
traditional medicines such as Chinese herbal medicines.
The therapeutic effects of a variety of herbal extracts have
been studied and reported worldwide. Among these, one of
the most investigated herbal extracts is curcumin (reviewed
in ref. [28]), which is isolated from the rhizome of Curcuma
longa (commonly known as turmeric). Curcumin has
been reported to have anti-cancer, anti-viral, anti-arthritic,
anti-amyloid, anti-oxidant, and anti-inflammatory properties,
and is considered a potential therapeutic agent in the
prevention and/or treatment of various malignant diseases,
arthritis, allergies, Alzheimer’s disease, inflammation and
OP [9-12]. This accumulation of evidence encouraged us to
Figure 5 Histochemical analysis of OB-specific phenotypes induced by herbal extracts. MC3T3E1 cells were seeded and allowed to
differentiate into mature OBs. Then, the cells were then cultured in the absence (Control) or presence of 10 μM AD, or 1, 10 and 100 μg/ml C.
atratum, M. azedarach and C. turtschaninovii extracts. After 3 days, cells were subjected to crystal violet (CV), ALPase activity (ALP) and alizarin red
(AR) staining, and examined under a microscope. Bar, 100 μm.
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Figure 6 Biochemical analysis and gene expression of OB-specific phenotypes induced by herbal extracts. A, MC3T3E1 cells were seeded
in 96-well cell culture plates and allowed to differentiate into mature OBs. Then, cells were then cultured in the absence (Control) or presence of 10 μM AD,
or 1, 10 and 100 μg/ml C. atratum (Atratum) M. azedarach (Azedarach) and C. turtschaninovii (Turtschaninovii) extracts. After 3 days, the cells were
subjected to MTT assay. B, C, D, E and F, MC3T3E1 cells were seeded in 24-well cell culture plates and allowed to differentiate into mature OBs. Thereafter,
cells were cultured in the absence (Control) or presence of 10 μM AD, or 1, 10 and 100 μg/ml C. atratum (Atratum) M. azedarach (Azedarach) and C.
turtschaninovii (Turtschaninovii) extracts. After 7 days, the cell layer was lysed with 300 μl of 0.02% Triton-X 100 in saline. The aliquot was then subjected
to DNA (B), ALPase activity (C), Ca (E), PO4 (F) measurement. The CM was also concentrated and subjected to ELISA for osteocalcin (D). Data are means
± standard deviation of 3 sets of cultures and each value (except for DNA) is standardized to DNA content (μg) in the cell layer. G and H, MC3T3E1 cells
were seeded and cultured, as described above. After 7 days, total cellular RNA was purified, and real-time RT-PCR for osteocalcin (G) and ALPase (H) was
carried out. Data are means ± standard deviation of 3 sets of cultures and each value is standardized to β-actin. *, p < 0.05 vs control.
Mukudai et al. BMC Complementary and Alternative Medicine 2014, 14:29 Page 9 of 14
http://www.biomedcentral.com/1472-6882/14/29explore the use of herbs other than C. longa for their
potential therapeutic effects in OP, and hence an institu-
tional collaborative project was commenced [13].
During bone remodeling [29], bone resorption by OCs
occurs prior to bone formation by OBs. It has beensuggested that suppression of proliferation and maturation
of OCs prevents excess bone loss. To this end, more
than 400 bioactive herbal products were subjected to
a preliminary screening utilizing RAW264.7 cells, and
we subsequently narrowed these candidates down to
Figure 7 Histochemical analysis of chondrocyte-specific phenotypes induced by herbal extracts. ATDC5 cells were seeded and allowed to
differentiate. Thereafter, cells were cultured in the absence (Control) or presence of 10 μM AD, or 1, 10 and 100 μg/ml of C. atratum, M. azedarach
and C. turtschaninovii extracts. After 3 days, cells were subjected to crystal violet (CV), ALPase activity (ALP) and toluidine blue (TB) staining, and
examined under a microscope. Bar, 100 μm.
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Figure 8 Biochemical analysis and gene expression of chondrocyte-specific phenotypes induced by herbal extracts. A, ATDC5 cells were
seeded in 96-well cell culture plates and allowed to differentiate. Thereafter, cells were cultured in the absence (Control) or presence of 10 μM AD,
or 1, 10 and 100 μg/ml C. atratum (Atratum) M. azedarach (Azedarach) and C. turtschaninovii (Turtschaninovii) extracts. After 3 days, cells were
subjected to MTT assay. B, C and D, ATDC5 cells were seeded in 24-well cell culture plates and allowed to differentiate. Thereafter, cells were cultured
in the absence (Control) or presence of 10 μM AD, or 1, 10 and 100 μg/ml C. atratum (Atratum) M. azedarach (Azedarach) and C. turtschaninovii
(Turtschaninovii) extracts. After 7 days, the cell layer was lysed with 300 μl of 0.02% Triton-X 100 in saline. The aliquot was then subjected to DNA
(B), ALPase activity (C) and sulfated GAG (D) measurement. Data are means ± standard deviation of 3 sets of cultures, and each value (except for DNA)
is standardized to DNA content (μg) in the cell layer. E, F and G, ATDC5 cells were seeded and cultured, as described above, and then total cellular
RNA was purified, and real-time RT-PCR for ALPase (E), aggrecan (F) and type II collagen (G) was carried out. Data are means ± standard deviation of
3 sets of cultures and each value is standardized to β-actin. *, p < 0.05 vs control.
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The bark ofM. azedarach has been utilized as a therapeutic
medicine for tinea imbricata in the Chinese pharmacopoeia
[18,19]. Methanolic extract of C. turtschaninovii has been
reported to have anti-allergic effects [15], and is used in
traditional Chinese medicine in the treatment of gastric and
duodenal ulcers, cardiac arrhythmic disease, rheumatism,
and dysmenorrhea [14]. Finally, the root bark extract of C.
atratum has been used as an anti-febrile and diuretic [16],
and has been reported to show anti-acetylcholinesterase
and anti-amnesic activities in vivo in mice [17].In addition to previous reports on pharmacological
availability, we showed in the present study that these
extracts are capable not only of suppressing proliferation
and/or maturation of OCs (Figure 2), but also of inducing
cell death (apoptosis) by increasing caspase activity
(Figure 3). The results of biochemical assays showed
inconsistencies with those of hystochemistry in part.
However, it is supposed that the former represents more
accurate results than the later does, since histochemical
staining often detects a non-specific artifact, and thereby,
shows inconsistent results. It is important to note that an
Figure 9 Histochemical analysis of primary MBM cells for differentiation induced by herbal extracts. MBM cells were seeded at a density
of 1.5×104 cells /well in 6-well tissue culture plates, and cultured with (Dif) or without (-) commercially available Osteoblast-Inducer Reagent, in
the absence (Control) or presence of 1 and 10 μg/ml C. atratum, M. azedarach, and C. turtschaninovii extracts. After 7 d, the cells were subjected
to ALPase activity (ALP) or TRAP staining. A, The cells were examined by a microscope, and photographed. Bar, 500 μm. B, The number of positive
cells was counted by a microscope, and means ± standard deviation of 3 individual fields were shown. *, p < 0.05 vs each control.
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protein ratio is required for apoptosis in various cells,
including OCs [30]. All of the extracts increased expression
of Bax, Bad and Bak, whereas the effects on expression of
Bcl-2 and Bcl-XL differed for each extract (Figure 4). On
the otherhand, AD increased p53 protein, as well as
Bax, Bad and Bak. In any case, the Bcl-2 pathway and
subsequent activation of caspase is involved in the
apoptotic effects observed with these compounds, and
interestingly, it is suggested thay the apoptotic signal
pathway might be different from that by BPs.
Since anti-OP therapeutics are required to have
minimal effects in reducing bone formation, we investigated
the effects of the herbal extracts on proliferation and
differentiation of OBs (Figures 5 and 6) and chondrocytes
(Figures 7 and 8) cell lines. All of the extracts exhibited
positive effects on partial, but not terminal, maturation of
OBs and chondrocytes, suggesting that these compounds
satisfy the requirements for therapeutics used in OP.
Finally, the extracts demonstrated the ability to induce
differentiation of OBs, but not OCs, from primary MBM
cells, reinforcing the effects of Osteoblast-Inducer Reagent,
albeit the effect was likely to be saturated at the high dosage
(10 μg/ml) of those extracts (Figure 9). The results from
the present study imply that we have successfully, at least
in part, uncovered a novel potential activity of these
extracts to be used as medicines for OP. We are of course
aware that further investigation, such as isolation and ana-
lysis of bioactive chemicals, detailed molecular and cellu-
lar experiments in vitro, and pre-clinical studies in vivo, is
required in order to ensure that there are not serious side
effects associated with the use of the herbal extracts, as
has been reported with chemically synthesized medicines.
Indeed, several of these studies are currently underway,
and our findings will be reported in the near future.
Conclusions
In the present study, we have successfully uncovered
a novel potential activity of three Chinese medical
herbal extracts from the root barks of M. azedarach,
C. turtschaninovii, and C. atratum to be used as medicines
for OP. All of the extracts showed capabilities of inducing
OCs to undergo apoptosis, OBs and chondrocyte to
differentiate, but not to grow. Moreover, the extracts
induced osteoblastic, but not osteoclastic differentiation in
primary MBM cells. In conclusion, these findings suggest
the feasibility of the use of these herbal extracts as novel
therapeutics in OP.
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